Increasing miR-451 Makes Lung Cancer Cells More Sensitive to Cisplatin
Author Information
Author(s): Bian Hai-Bo, Pan Xuan, Yang Jin-Song, Wang Zhao-Xia, De Wei
Primary Institution: The Second Affiliated Hospital of Nanjing Medical University
Hypothesis
Can upregulation of miR-451 affect the sensitivity of non-small cell lung cancer (NSCLC) cells to cisplatin?
Conclusion
Upregulation of miR-451 enhances the sensitivity of A549 cells to cisplatin by inducing apoptosis.
Supporting Evidence
- MiR-451 levels were significantly higher in NSCLC tissues compared to noncancerous tissues.
- Ectopic overexpression of miR-451 inhibited growth and induced apoptosis in A549 cells.
- Upregulation of miR-451 increased sensitivity of A549 cells to cisplatin in both in vitro and in vivo experiments.
Takeaway
This study found that increasing a tiny molecule called miR-451 helps lung cancer cells respond better to a common cancer drug, making it easier to treat the disease.
Methodology
The study used quantitative RT-PCR to measure miR-451 levels in tissue samples and conducted various assays to evaluate cell growth, apoptosis, and drug sensitivity.
Limitations
The study only used one cell line (A549) and did not explore other potential cell lines.
Participant Demographics
Patients with non-small cell lung cancer (NSCLC) from Nanjing Chest Hospital.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website